menu
    • menu

    Company profile for Orasis Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ORASIS IS DEVELOPING a corrective eye drop to treat presbyopia as an alternative to reading glasses. Presbyopia, the inability to focus on near objects, typically occurs after the age of 40 and affects more than 1.8 billion people worldwide. Our product is an eye drop being developed to improve the quality of life for people with presbyopia by alleviating the burden of reading glasses. By repurposing existing and well-stu...
    ORASIS IS DEVELOPING a corrective eye drop to treat presbyopia as an alternative to reading glasses. Presbyopia, the inability to focus on near objects, typically occurs after the age of 40 and affects more than 1.8 billion people worldwide. Our product is an eye drop being developed to improve the quality of life for people with presbyopia by alleviating the burden of reading glasses. By repurposing existing and well-studied molecules, our winning combination targets the right balance of efficacy, safety and comfort.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orasis PharmaceuticalsIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    6 Maskit St., Herzliya P.O.B 12929, 4673328 Israel
    Telephone
    Telephone
    +972-9-8877745
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.orasis-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orasis-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orasis Pharmaceuticals Expands Access to Qlosi
    Orasis Pharmaceuticals Expands Access to Qlosi

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-expands-access-to-qlosi-with-new-starter-packs-for-eye-care-professionals-bolstering-commerical-rollout-302613523.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Orasis Pharmaceuticals Licenses Qlosi™ Ophthalmic Solution In Korea
    Orasis Pharmaceuticals Licenses Qlosi™ Ophthalmic Solution In Korea

    16 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-licensing-agreement-with-optus-pharmaceuticals-for-commercialization-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-in-korea-302277027.html

    PR NEWSWIRE
    16 Oct 2024
    Share Share
    Orasis Pharmaceuticals Strengthens Leadership Team For Qlosi
    Orasis Pharmaceuticals Strengthens Leadership Team For Qlosi

    14 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-strengthens-leadership-team-with-key-hires-to-support-the-launch-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-302274366.html

    PR NEWSWIRE
    14 Oct 2024
    Share Share
    Orasis Pharma Completes $78 Million Financing to Launch Qlosia
    Orasis Pharma Completes $78 Million Financing to Launch Qlosia

    08 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-completes-78-million-financing-to-support-commercial-launch-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-302269236.html

    PR NEWSWIRE
    08 Oct 2024
    Share Share
    Orasis gains FDA approval for presbyopia eye drops
    Orasis gains FDA approval for presbyopia eye drops

    19 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-fda-approval-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-for-the-treatment-of-presbyopia-301959581.html

    PR NEWSWIRE
    19 Oct 2023
    Share Share
    Orasis Announces Ph2b Trial Efficacy and Safety Results of Novel Eye Drop
    Orasis Announces Ph2b Trial Efficacy and Safety Results of Novel Eye Drop

    25 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-phase-2b-trial-efficacy-and-safety-results-of-novel-presbyopia-eye-drop-candidate-csf-1-at-the-2022-american-society-of-cataract-and-refractive-surgery-ascrs-annual-meeting-301530823.html

    PRNEWSWIRE
    25 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search